Radiologic progressive disease (i.e., tumor progression) during treatment failure due to uncontrolled seizures was present in 40% (2/5) of patients who used LEV + VPA + CLB compared with 13% (1/8) who used other triple therapy combinations. This evidence concerns the gene CLYBL and neoplasm.